These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3460090)

  • 1. Mechanism of cytotoxicity of human large granular lymphocytes: relationship of the cytotoxic lymphocyte protein to the ninth component (C9) of human complement.
    Zalman LS; Brothers MA; Chiu FJ; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5262-6. PubMed ID: 3460090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytolytic protein of human lymphocytes related to the ninth component (C9) of human complement: isolation from anti-CD3-activated peripheral blood mononuclear cells.
    Zalman LS; Martin DE; Jung G; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2426-9. PubMed ID: 3494251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis of target cell killing by human lymphocytes and of killer cell self-protection.
    Müller-Eberhard HJ
    Immunol Rev; 1988 Mar; 103():87-98. PubMed ID: 3292398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of cytotoxicity: comparison of complement and killer lymphocytes.
    Müller-Eberhard HJ; Zalman LS; Chiu FJ; Jung G; Martin DE
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():28-34. PubMed ID: 3612651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of synthesis of the cytolytic C9 (ninth component of complement)-related protein in human peripheral mononuclear cells by monoclonal antibody OKT3 or interleukin 2: correlation with cytotoxicity and lymphocyte phenotype.
    Martin DE; Zalman LS; Jung G; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2946-50. PubMed ID: 3495005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A C9 related channel forming protein in the cytoplasmic granules of human large granular lymphocytes.
    Zalman LS; Brothers MA; Müller-Eberhard HJ
    Biosci Rep; 1985 Dec; 5(12):1093-100. PubMed ID: 3830274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
    Tschopp J; Masson D; Stanley KK
    Nature; 1986 Aug 28-Sep 3; 322(6082):831-4. PubMed ID: 2427956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities.
    Young JD; Cohn ZA; Podack ER
    Science; 1986 Jul; 233(4760):184-90. PubMed ID: 2425429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
    Falk RJ; Dalmasso AP; Kim Y; Tsai CH; Scheinman JI; Gewurz H; Michael AF
    J Clin Invest; 1983 Aug; 72(2):560-73. PubMed ID: 6348093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement channels in membranes: inhibition with a monoclonal antibody to a neoantigen of polymerized C9.
    Dalmasso AP; Benson BA; Falk RJ
    Biochem Biophys Res Commun; 1984 Dec; 125(3):1013-9. PubMed ID: 6517929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-protection of cytotoxic lymphocytes: a soluble form of homologous restriction factor in cytoplasmic granules.
    Zalman LS; Brothers MA; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4827-31. PubMed ID: 3260383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing of human melanoma cells by the membrane attack complex of human complement as a function of its molecular composition.
    Martin DE; Chiu FJ; Gigli I; Müller-Eberhard HJ
    J Clin Invest; 1987 Jul; 80(1):226-33. PubMed ID: 3597774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.
    Zalman LS; Wood LM; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6975-9. PubMed ID: 2428045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of refolding conformers of complement protein C9 during insertion into membranes.
    Laine RO; Esser AF
    Nature; 1989 Sep; 341(6237):63-5. PubMed ID: 2475785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoaffinity purification of human complement component C9 using monoclonal antibodies.
    Morgan BP; Daw RA; Siddle K; Luzio JP; Campbell AK
    J Immunol Methods; 1983 Nov; 64(3):269-81. PubMed ID: 6199425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.
    Tschopp J; Mollnes TE
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4223-7. PubMed ID: 2424021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular phosphorylation of C9 by protein kinase CK2 regulates complement-mediated lysis.
    Bohana-Kashtan O; Pinna LA; Fishelson Z
    Eur J Immunol; 2005 Jun; 35(6):1939-48. PubMed ID: 15902683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
    Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
    Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane attack complex of complement in dermatitis herpetiformis.
    Dahl MV; Falk RJ; Carpenter R; Michael AF
    Arch Dermatol; 1985 Jan; 121(1):70-2. PubMed ID: 3881089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
    Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K
    Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.